Guido Koch*a, Olivier Loiseleurb, Karl-Heinz Altmannc a Novartis Institutes for Biomedical Research, WSJ-507.704, 4002 Basel, Switzerland Fax: +41(61)32442 38; e-Mail: guido.koch@pharma.novartis.com; b Syngenta AG, WRO-1060.5.04, 4002 Basel, Switzerland c ETH Zürich, Department of Chemistry and Applied BioSciences, Institute of Pharmaceutical Sciences, Winterthurerstr.190, 8057 Zürich, Switzerland